Comment on: Is clozapine use a risk of hematological malignancies? Insights from a meta‐analysis “Clozapine and Malignancy Risk”
This article relates to Comment on: Is clozapine use a risk of hematological malignancies? Insights from a meta-analysis "Clozapine and Malignancy Risk".
Authors
- Basile Chrétien (ORCID: https://orcid.org/0000-0002-7483-2489)
- Kazuki Nishida (ORCID: https://orcid.org/0000-0003-0367-8557)
Institutions
- Inserm (FR)
- Kyoto University (JP)
- Normandie Université (FR)
- Cyceron (FR)
- Physiopathologie et imagerie des troubles neurologiques
- Nagoya University (JP)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Psychiatry and Clinical Neurosciences
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1111/pcn.13839
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47